Javascript must be enabled to continue!
Increasing Skeletal Muscle Carnitine Availability During High Intensity Interval Training
View through CrossRef
Increasing skeletal muscle carnitine availability increases pyruvate dehydrogenase (PDC) flux during continuous exercise at 80% maximal aerobic capacity (VO
2
max
−
), as evidenced by greater free carnitine acetylation [1]. Whether free carnitine availability is limiting to PDC flux and mitochondrial ATP production during consecutive bouts of more intense exercise is unclear. If it is, then increasing carnitine availability during high‐intensity interval training (HIT) could serve to enhance the gains to this type of exercise.
In seven healthy male volunteers (age 23 ± 4 years; BMI 23.6 ± 2.0 kg/m
2
; VO
2
max 48 ± 6 ml/kg/min) we determined skeletal muscle carnitine, PDC activation status, glycogenolysis and non‐mitochondrial ATP production (NMAP; from changes in phosphocreatine [PCr], lactate and ATP concentrations) during two 3 minute bouts of cycling exercise at 100% VO
2
max separated by 5 minutes recovery (Study A). In a further 14 volunteers (23.2 ± 1.1 years; 24.4 ± 0.9 kg/m
2
; 41.6 ± 2.1 ml/kg/min) we subsequently investigated the effects of twice daily L‐carnitine (1.5 g) and carbohydrate (80 g) supplementation (CARN) during 24 weeks of HIT (3×3 min at 100% VO
2
max thrice weekly), versus HIT with carbohydrate alone (CON; Study B). In addition to the same outcome measures in study A, study B included VO
2
max, work output, and mechanical efficiency. Both studies were approved by local ethics committee
In study A, muscle free carnitine declined similarly by 33% and 41%, whilst PDC activation increased 3 and 5‐fold, during bout one and bout two, respectively. Glycogenolysis tended to increase 2‐fold (54 ± 14 [bout one] vs. 99 ± 18 [bout two] mmol/kg dw; P=0.1) and although NMAP was not significantly different between bouts (158 ± 14 [bout one] vs. 110 ± 40 [bout two] mmol/kg dw; P=0.29), PCr degradation was 2‐fold greater during bout two (29 ± 9 [bout one] vs. 61 ± 8 [bout two] mmol/kg dw; P<0.05).
In study B, the change in muscle total carnitine following HIT was greater in CARN than CON (1.5 ± 0.7 [CARN] vs. −0.9 ± 0.6 [CON] mmol/kg dw; P<0.05), resulting in elevated free carnitine concentrations in CARN throughout bout one and prior to the start of bout two compared to CON (P<0.05). During bout one, NMAP was significantly lower following training in CARN (P<0.05) but not CON, whilst glycogenolysis was unchanged in both groups. During bout two, the HIT‐induced reduction in NMAP (~60%; P<0.01) and glycogenolysis (~60%; P<0.05) was similar between CON and CARN. Likewise, the overall improvements in VO
2
max (11% [CON] vs. 8% [CARN]) and work output (28% [CON] vs. 18% [CARN]) following HIT were similar between groups. However, mechanical efficiency increased in CARN only, such that the change from baseline was greater than in CON (1.9 ± 0.8 [CARN] and −0.2 ± 0.7% [CON]; P<0.05).
This novel data demonstrate that mitochondrial ATP production declines during a second bout of intense fixed workload cycling. However, increasing muscle carnitine availability during a 24 week period of HIT does not prevent this decline, despite improving efficiency during a first bout. As such, increasing muscle carnitine did not enhance the gains in exercise performance and capacity beyond the robust adaptations observed here with HIT training alone.
Support or Funding Information
BBSRC DTA Studentship
Title: Increasing Skeletal Muscle Carnitine Availability During High Intensity Interval Training
Description:
Increasing skeletal muscle carnitine availability increases pyruvate dehydrogenase (PDC) flux during continuous exercise at 80% maximal aerobic capacity (VO
2
max
−
), as evidenced by greater free carnitine acetylation [1].
Whether free carnitine availability is limiting to PDC flux and mitochondrial ATP production during consecutive bouts of more intense exercise is unclear.
If it is, then increasing carnitine availability during high‐intensity interval training (HIT) could serve to enhance the gains to this type of exercise.
In seven healthy male volunteers (age 23 ± 4 years; BMI 23.
6 ± 2.
0 kg/m
2
; VO
2
max 48 ± 6 ml/kg/min) we determined skeletal muscle carnitine, PDC activation status, glycogenolysis and non‐mitochondrial ATP production (NMAP; from changes in phosphocreatine [PCr], lactate and ATP concentrations) during two 3 minute bouts of cycling exercise at 100% VO
2
max separated by 5 minutes recovery (Study A).
In a further 14 volunteers (23.
2 ± 1.
1 years; 24.
4 ± 0.
9 kg/m
2
; 41.
6 ± 2.
1 ml/kg/min) we subsequently investigated the effects of twice daily L‐carnitine (1.
5 g) and carbohydrate (80 g) supplementation (CARN) during 24 weeks of HIT (3×3 min at 100% VO
2
max thrice weekly), versus HIT with carbohydrate alone (CON; Study B).
In addition to the same outcome measures in study A, study B included VO
2
max, work output, and mechanical efficiency.
Both studies were approved by local ethics committee
In study A, muscle free carnitine declined similarly by 33% and 41%, whilst PDC activation increased 3 and 5‐fold, during bout one and bout two, respectively.
Glycogenolysis tended to increase 2‐fold (54 ± 14 [bout one] vs.
99 ± 18 [bout two] mmol/kg dw; P=0.
1) and although NMAP was not significantly different between bouts (158 ± 14 [bout one] vs.
110 ± 40 [bout two] mmol/kg dw; P=0.
29), PCr degradation was 2‐fold greater during bout two (29 ± 9 [bout one] vs.
61 ± 8 [bout two] mmol/kg dw; P<0.
05).
In study B, the change in muscle total carnitine following HIT was greater in CARN than CON (1.
5 ± 0.
7 [CARN] vs.
−0.
9 ± 0.
6 [CON] mmol/kg dw; P<0.
05), resulting in elevated free carnitine concentrations in CARN throughout bout one and prior to the start of bout two compared to CON (P<0.
05).
During bout one, NMAP was significantly lower following training in CARN (P<0.
05) but not CON, whilst glycogenolysis was unchanged in both groups.
During bout two, the HIT‐induced reduction in NMAP (~60%; P<0.
01) and glycogenolysis (~60%; P<0.
05) was similar between CON and CARN.
Likewise, the overall improvements in VO
2
max (11% [CON] vs.
8% [CARN]) and work output (28% [CON] vs.
18% [CARN]) following HIT were similar between groups.
However, mechanical efficiency increased in CARN only, such that the change from baseline was greater than in CON (1.
9 ± 0.
8 [CARN] and −0.
2 ± 0.
7% [CON]; P<0.
05).
This novel data demonstrate that mitochondrial ATP production declines during a second bout of intense fixed workload cycling.
However, increasing muscle carnitine availability during a 24 week period of HIT does not prevent this decline, despite improving efficiency during a first bout.
As such, increasing muscle carnitine did not enhance the gains in exercise performance and capacity beyond the robust adaptations observed here with HIT training alone.
Support or Funding Information
BBSRC DTA Studentship.
Related Results
Carnitine Inborn Errors of Metabolism
Carnitine Inborn Errors of Metabolism
Carnitine plays essential roles in intermediary metabolism. In non-vegetarians, most of carnitine sources (~75%) are obtained from diet whereas endogenous synthesis accounts for ar...
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives:
Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substanti...
Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?
Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?
l-Carnitine is an amino acid derivative widely known for its involvement in the transport of long-chain fatty acids into the mitochondrial matrix, where fatty acid oxidation occurs...
Role of carnitine in regulation of hypoglycemia-induced hypertension and cardiac hypertrophy
Role of carnitine in regulation of hypoglycemia-induced hypertension and cardiac hypertrophy
Abstract
Background: Cardiovascular disease is a leading cause of death in diabetic patients. Hyperglycemia and iatrogenic hypoglycemia exacerbate several pathogenic mechan...
Progression of Cisplatin-Induced Nephrotoxicity in a Carnitine-Depleted Rat Model
Progression of Cisplatin-Induced Nephrotoxicity in a Carnitine-Depleted Rat Model
<i>Background:</i> This study has been initiated to investigate whether endogenous carnitine depletion and/or carnitine deficiency is an additional risk factor and/or a...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Fluorometric determination of carnitine in serum with immobilized carnitine dehydrogenase and diaphorase
Fluorometric determination of carnitine in serum with immobilized carnitine dehydrogenase and diaphorase
Abstract
A fluorometric flow-injection method for determining carnitine with use of immobilized enzymes carnitine dehydrogenase (EC 1.1.1.108) and diaphorase (EC 1.8...
Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine‐loaded liposomes
Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine‐loaded liposomes
Carnitine transporters have recently been implicated in susceptibility to inflammatory bowel disease (IBD). Because carnitine is required for β‐oxidation, it was suggested that dec...

